Ngee Ann Polytechnic’s School of Life Sciences and Chemical Technology (LSCT) is proud to announce a groundbreaking partnership with Merck Singapore (Merck Life Science) through the signing of a Memorandum of Understanding (MoU). This strategic collaboration aims to revolutionize the learning experience for students pursuing Chemical and Biomolecular Engineering by equipping them with industry-relevant skills and hands-on training.

Under this partnership, Ngee Ann Polytechnic and Merck Singapore will co-design and co-deliver specialized biopharmaceutical manufacturing modules to benefit 75 final-year students from LSCT each year. The initiative is designed to bridge the gap between academic learning and real-world applications, empowering students with knowledge that aligns with the evolving demands of the pharmaceutical and biopharmaceutical industries.

Key highlights of the collaboration include:

• Access to Merck’s Cutting-Edge Technologies: Students will gain exposure to advanced technologies used in biopharmaceutical manufacturing.
• Internship Opportunities: The partnership provides students with a gateway to internships, enabling them to gain valuable industry experience and kickstart their careers.
• Skill Development: The modules will focus on practical, hands-on training to prepare students for the dynamic landscape of biopharma manufacturing.

“We are thrilled to partner with Merck Singapore to offer our students a unique opportunity to develop industry-ready skills,” said spoeksperson at Ngee Ann Polytechnic. “This collaboration underscores our commitment to providing innovative education and fostering the next generation of biochemical talent in Singapore.”

“Merck is dedicated to supporting the growth of talent in the biopharmaceutical sector,” said spokesperson at Merck Singapore. “By working closely with Ngee Ann Polytechnic, we aim to inspire and equip students with the tools and knowledge needed to thrive in this fast-growing industry.”

This partnership aligns with Singapore’s vision to strengthen its position as a global biopharmaceutical hub by nurturing a pipeline of skilled professionals who will drive innovation and growth in the sector.